NIKKEI 225
38,703.51 +213.34 (+0.55%) HANG SENG
18,432.21 +7.25 (+0.04%) CRUDE OIL
74.49 +0.42 (+0.57%) GOLD FUTURES
2,384.80 +9.30 (+0.39%) DOW
38,807.33 +96.04 (+0.25%) Bitcoin GBP
55,431.23 -60.55 (-0.11%)
Sotera Health Company (SHC)
After hours:
| Previous close | 11.64 |
| Open | 11.74 |
| Bid | 11.97 x 300 |
| Ask | 12.03 x 100 |
| Day's range | 11.50 - 11.99 |
| 52-week range | 10.71 - 19.40 |
| Volume | |
| Avg. volume | 1,415,901 |
| Market cap | 3.391B |
| Beta (5Y monthly) | 2.09 |
| PE ratio (TTM) | 63.05 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Sotera Health Announces Closing of $1.5 Billion Term Loan B and $750 Million Senior Secured Note Financings
CLEVELAND, May 30, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced that its direct subsidiary has successfully closed a new senior secured Term Loan B facility in an aggregate principal amount of $1.51 billion (the “TLB”) as well as an issuance of senior secured notes in an aggregate pr
- GlobeNewswire
Sotera Health Reports First-Quarter 2024 Results
Q1 2024 net revenues increased 12.5% to $248 million, compared to Q1 2023Q1 2024 net income of $6 million or $0.02 per diluted share, compared to net income of $3 million or $0.01 per diluted share in Q1 2023Q1 2024 Adjusted EBITDA(1) increased 13.7% to $112 million, compared to Q1 2023Q1 2024 Adjusted EPS(1) of $0.13 compared to Adjusted EPS of $0.13 in Q1 2023Company reaffirms 2024 outlook CLEVELAND, May 02, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nas
- GlobeNewswire
Sotera Health Announces First-Quarter 2024 Earnings Release Date
CLEVELAND, April 11, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the first-quarter ended March 31, 2024 before the market opens on Thursday, May 2, 2024. Following the release, management will hold a conference call at 9:00 a.m. Eastern Time to discuss the Company’s oper
